Invivo Capital Partners logo

Invivo Capital Partners

Europe, Catalonia, Spain, Barcelona

Description

Invivo Capital is a management firm that invests in startup healthcare enterprises.

Investor Profile

Invivo Capital Partners has made 18 investments, with 3 in the past 12 months and 44% as lead.

Stage Focus

  • Seed (56%)
  • Series Unknown (22%)
  • Series A (17%)
  • Series B (6%)

Country Focus

  • Spain (61%)
  • France (22%)
  • Denmark (6%)
  • Belgium (6%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Health Care
  • Agriculture
  • Genetics
  • Financial Services
  • Insurance
  • Food And Beverage
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Invivo Capital Partners frequently co-invest with?

AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
ICREA
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Angelini Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 1
Innovestor
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
JC
Europe, Catalonia, Spain, Badalona
Co-Investments: 2
NC
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Co-Investments: 3

What are some of recent deals done by Invivo Capital Partners?

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.

ManufacturingPharmaceutical
Series UnknownMar 18, 2025
Neumirna Therapeutics

Copenhagen, Hovedstaden, Denmark

Neumirna Therapeutics is a Danish pharmaceutical start-up based in Copenhagen.

Pharmaceutical
Series AJan 8, 2025
Amount Raised: $20,708,264
Gyala Therapeutics

Barcelona, Catalonia, Spain

Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.

BiotechnologyLife ScienceTherapeutics
Series UnknownOct 14, 2024
EsoBiotec

Mont-saint-guibert, Brabant Wallon, Belgium

soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

Biotechnology
Series ADec 12, 2023
Amount Raised: $2,159,699
Corteria Pharmaceuticals

Paris, Ile-de-France, France

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

BiotechnologyPharmaceuticalTherapeutics
Series ASep 7, 2023
Amount Raised: $69,538,574
OneChain Immunotherapeutics

Barcelona, Catalonia, Spain

OCI develops therapies for leukaemia based on CAR–T.

BiotechnologyLife Science
SeedJun 22, 2023
Amount Raised: $7,340,197
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BMay 3, 2023
Amount Raised: $46,487,689
Atekka

Paris, Ile-de-France, France

Atekka is a new generation agricultural insurance company.

AgricultureFinancial ServicesInsurance
Series UnknownSep 19, 2022
Amount Raised: $4,914,803
Corteria Pharmaceuticals

Paris, Ile-de-France, France

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

BiotechnologyPharmaceuticalTherapeutics
SeedDec 9, 2021
Amount Raised: $13,552,400
Integra Therapeutics

Barcelona, Catalonia, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

BiotechnologyGeneticsHealth Care
SeedDec 2, 2021
Amount Raised: $5,087,695